Short-term and long-term effects of Sanming healthcare system reform on drug-related expenditures for rural patients with cancer in public hospitals: an interrupted time series analysis using segmented regression model in China

Abstract

ObjectivesTo assess the effects of ‘Sanming model’ on drug-related expenditures.DesignInterrupted time series analysis with two time points was conducted to analyse the effects of ‘Sanming model’ using segmented regression model.SettingTwo hundred and eighty public hospitals in Fujian province in China.ParticipantsA total of 777 171 inpatients and 792 743 outpatients with cancer who participated in New Rural Cooperative Medical Scheme (NRCMS) were included.Interventions‘Sanming model’ was issued by Sanming government in February 2013 and spread to other cities in Fujian province in January 2015.Primary outcome measuresFour drug-related expenditure variables.ResultsAmong inpatients, total drug expenditures and drug expenditures covered by NRCMS dropped instantly after the reform in all hospitals. Although there was insignificant change during the short-term reform period, the total drug expenditures and drug expenditures covered by NRCMS decreased at the rate of ¥20.3 (p=0.0099) and ¥18.8 (p=0.0341) per capita month-to-month during the long-term reform period in Sanming hospitals, respectively. Among outpatients, total drug expenditures and drug expenditures covered by NRCMS decreased at the rate of ¥20.8 (p=0.0335) and ¥18.4 (p=0.0242) per capita month-to-month during the short-term reform period in Sanming hospitals, respectively. However, the downward trend did not continue into the long term. The significant decreases in trend of drug expenditures uncovered by NRCMS were only observed after the reform in provincial hospitals. The ratio of drug expenditures to inpatient (outpatient) expenditures decreased after the reform in all hospitals.Conclusions‘Sanming model’ had long-term effect in reducing total drug expenditures, drug ratio and drug expenditures covered by NRCMS for rural inpatients with cancer and only short-term positive effect for outpatients. However, there was limited effect of ‘Sanming model’ on drug expenditures uncovered by NRCMS. ‘Sanming model’ still needs to accumulate experiences and improves the reform measures dynamically.